Profil
Leon J de Windt is the founder of Lead Pharma Holding BV, which was founded in 2007.
He is also the founder of Mirabilis Therapeutics BV, which was founded in 2015.
At Mirabilis Therapeutics BV, he held the title of Chief Scientific Officer.
Dr. de Windt's former job was as an Assistant Professor at The Royal Netherlands Academy of Arts & Sciences.
He obtained a doctorate degree from Maastricht University in 1999 and a graduate degree from the University of Utrecht in 1993.
Anciens postes connus de Leon J de Windt
| Sociétés | Poste | Fin |
|---|---|---|
The Royal Netherlands Academy of Arts & Sciences
The Royal Netherlands Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services Provides research services in the field on science and art | Corporate Officer/Principal | - |
Mirabilis Therapeutics BV
Mirabilis Therapeutics BV Pharmaceuticals: MajorHealth Technology Develops microRNA medicines | Fondateur | - |
Lead Pharma Holding BV
Lead Pharma Holding BV Pharmaceuticals: MajorHealth Technology Develops small-molecule drugs for the treatment of autoimmune diseases and cancer | Fondateur | - |
Formation de Leon J de Windt
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Maastricht University
Maastricht University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Utrecht
University of Utrecht Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Royal Netherlands Academy of Arts & Sciences
The Royal Netherlands Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services Provides research services in the field on science and art | Commercial Services |
Lead Pharma Holding BV
Lead Pharma Holding BV Pharmaceuticals: MajorHealth Technology Develops small-molecule drugs for the treatment of autoimmune diseases and cancer | Health Technology |
Mirabilis Therapeutics BV
Mirabilis Therapeutics BV Pharmaceuticals: MajorHealth Technology Develops microRNA medicines | Health Technology |
















